K-numberK244012
Device nameMosaic (V1.0.1)
ApplicantNavier Medical
Product codeLLZ
Device classClass II
Decision dateJun 16, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Mosaic V1.0.1 is a medical image analysis software that processes CT angiography scans to help trained medical professionals evaluate arterial diseases, including atherosclerosis and aneurysms in the aorta, carotid, iliac, femoral, and popliteal arteries. It provides tools for vessel measurement, visualization, and analysis including diameter, length, volume, stenosis, and positive remodeling calculations, but is not intended to provide diagnosis or replace clinical judgment.

Technological characteristics

Mosaic V1.0.1 shares all major technological features with the predicate ElucidVivo A.3: Windows OS compatibility, DICOM image input, CT acquisition source, Hounsfield Unit-based segmentation, 2D and 3D imaging, multiplanar reformatting, 2D measurements, vessel stenosis analysis, volumetric measurements, positive remodeling index calculation, and PDF reporting. A minor difference is Mosaic uses calcified tissue threshold >350 HU (versus >250 HU in predicate) and employs an adaptive algorithm for low-attenuating plaque detection.

Test standards cited

Not stated in this summary. The document references FDA guidance on General Principles of Software Validation, Guidance for Content of Premarket Submissions for Software Contained in Medical Devices, and Content of Premarket Submission for Management of Cybersecurity in Medical Devices, but does not cite specific ISO, IEC, or ASTM consensus standards.

Substantial equivalence argument

Mosaic is substantially equivalent because it performs the identical intended function as ElucidVivo A.3 (post-processing CT images for arterial disease analysis) using the same fundamental technological approach and features. Validation testing demonstrated measurements from Mosaic are substantially equivalent to ElucidVivo across diameter, tissue volume, stenosis, and positive remodeling index with comparable bias and root mean square error across the intended clinical ranges. The minor threshold adjustments for tissue characterization represent refinements rather than functional differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →